ʻO ka Peptide Synthesis — E kūkulu i ka noi a puni kahi kuhiakau hoʻāʻo

Pane wikiwiki

A useful custom peptide synthesis brief explains what comparison the experiment must make. Sequence and quantity fields come next. If the scientific question i…

ʻO ka Peptide Synthesis — E kūkulu i ka noi a puni kahi kuhiakau hoʻāʻo

A useful custom peptide synthesis brief explains what comparison the experiment must make. Sequence and quantity fields come next. If the scientific question is unclear, a supplier can deliver exactly what was ordered while the laboratory still lacks the controls or evidence needed to interpret the result.

Pāhana kuhiakau: Nīnau kahi hui inā hoʻololi ka acetylation N-terminal i kahi pilina peptide pōkole me kahi pahuhopu hoʻomaʻemaʻe i kahi hoʻopaʻa paʻa i wehewehe ʻia.. ʻO ke kaʻina aʻo ʻana ʻo ASVQTKG, me ka waika C-terminal manuahi a me ka hoʻonohonoho L i nā koena chiral. ʻO nā palapala noi ʻelua ʻo H-ASVQTKG-OH a me Ac-ASVQTKG-OH. ʻO Glycine ka achiral.

ʻAʻohe hana paʻa, hopena hoʻohui, manaʻo ʻia ka hopena solubility. ʻO nā ʻano acetylated a me unacetylated kahi hoʻohālikelike hoʻohālikelike, ʻaʻole ʻokoʻa ka mana maikaʻi a maikaʻi ʻole. Pono ka hoʻokolohua i nā mana e hoʻoponopono i kāna heluhelu ʻana a me kona ʻano.

Manaʻo kaʻawale ʻekolu mau ʻano noi: ʻano hoʻopau, ka nui i koho ʻia, a me ka laulā analytical. Kōkua kēia ʻokoʻa i ka hui e ʻike i ka hoʻololi e hoʻāʻo ai i ke kuhiakau a me nā loli e pili ana i ka lako a i ʻole ka hilinaʻi i ka hoʻohālikelike.

Hoʻokahi hoʻololi: change terminal form while preserving the rest of the target

Hoʻololi ka hoʻohālikelike ʻepekema i ka pūʻulu N-terminal me ka mālama ʻana i ke kaʻina, Kemika C-terminal, hoʻonohonoho, a me nā hiʻohiʻona like ʻole. ʻAʻole i manaʻo ʻia ke kaulahao ʻaoʻao lysine e acetylated. E haʻi pololei ma mua o ka hilinaʻi ʻana i ka huaʻōlelo "acetylated peptide."

ʻO ka Peptide Synthesis — E kūkulu i ka noi a puni kahi kuhiakau hoʻāʻo

E wehewehe pono i kahi o ka hui acetyl. ʻO ka kūlana kūlana ProForma kākoʻo i nā ʻano peptide ʻike pūnaewele. Ma ASVQTKG, ʻO ka acetylation N-terminal a me ka lysine-side-chain acetylation he mau pahuhopu ʻokoʻa inā ʻaʻole hiki ke hoʻokaʻawale ʻia ka haku mele ʻana..

Hoʻololi ka N-terminal acetylation i ka hui kemika kūloko a hiki ke hoʻopilikia i nā waiwai pili i ka pilina. ʻO ke kuhikuhi o kekahi paʻa, hikiwawe, ʻAʻole ʻike ʻia ka hopena hoʻihoʻi no kēia kaʻina a me ka ʻōnaehana hypothetical. Mai koho i ke ʻano i hoʻololi ʻia no ka mea, ʻōlelo ka acetylation i ke kūpaʻa a i ʻole ka hana.

Separate an affinity question from a presentation effect

Inā hoʻopili ka hoʻokolohua i ka peptide ma o nā amine mua hiki ke loaʻa, hiki ke hoʻololi i ke kumu hoʻopili i loaʻa i ka pale ʻana i ka amine N-terminal. ʻO ka ʻano unacetylated ka hui N-terminal a me ka Lys6 side-chain amine e noʻonoʻo ai; ʻAʻole hōʻike ka ʻano N-acetylated i ka hoʻonohonoho like. No laila, hiki ke ho'ololi 'ia ka 'ao'ao o ka attachment a i 'ole ka nui o ka ilikai ma ka 'ao'ao o ka hi'ona mole e a'o 'ia nei.

He nīnau hoʻolālā kēia, ʻAʻole hōʻike e pili ana ka peptide i ʻoi aku ka maikaʻi. E hoʻoholo inā pili ka kuhiakau i manaʻo ʻia i nā mea i hōʻike ʻia ma ke ʻano holoʻokoʻa a i ʻole ka hopena o ka acetylation ma lalo o kahi hōʻike hoʻomalu.. Inā makemake ʻia kahi hoʻolālā hoʻopili maʻamau, e wehewehe pono i ka hui ʻenehana ma mua o ka manaʻo ʻana ua hoʻopuka ka hoʻokomo hoʻonā like i nā ʻili like..

Polypetide Hoʻohālike pane i haku ʻia. E noʻonoʻo i kahi hiʻohiʻona maʻalahi ʻole o ka hope R = Rmax × c/(K + c), hoʻohana wale ʻia e hōʻike i ka wehewehe. E waiho K = 10 na huina hookuonoono a me c = 10 no nā mea ʻelua. Me Rmax = 100, ka pane 50; me Rmax = 50, ʻo ia 25. ʻOkoʻa ʻelua ʻokoʻa nā pane ʻoiai ua like ke K ma kēia kükohu.

ʻO ka Peptide Synthesis — E kūkulu i ka noi a puni kahi kuhiakau hoʻāʻo

No laila hiki ke kūpono i kahi hōʻailona haʻahaʻa haʻahaʻa me ka hiki ke ana i hoʻemi ʻia ma mua o ka hoʻololi ʻana i ka pilina. Hiki ke haʻalele i kēia ʻano hoʻohālike maʻalahi ma o ka hope, nonequilibrium ka hana a i ʻole nā ​​hopena ʻē aʻe. Mai hoʻopili a wehewehe paha i kahi waiwai pili no ka mea hiki ke kākau ʻia ka hoohalike aʻo. E wehewehe i nā ʻike e pono ai, nā manaʻo a me nā mana me ka hui assay.

E noi i nā kumu helu like a me ka uhi analytical no nā ʻano ʻelua. Inā loaʻa i kekahi hoʻomākaukau kahi hoʻonohonoho kikoʻī a ʻo kekahi ʻo ka pauda nui wale nō, hiki i ka hoʻohālikelike ʻano like ke hoʻohui i nā hopena molecular-form me ka hoʻokomo like ʻole.

Pono ka loiloi mua e ʻike i ka hui kūpono, ka hoomaemae ana, a me ka hoʻomākaukau ʻana i nā nīnau me ka ʻōlelo ʻole i ka holomua. Hiki i ka mea hoʻolako ke nānā i ka hiki, oiai e pono ke keena hana Hoʻolako Peptide e hoʻoholo inā makemake ka mea i manaʻo ʻia a me ka heluhelu ʻana i ka hana kūpono. ʻAʻole kahi kaʻina pōkole a i ʻole kahi hoʻololi maʻamau e hōʻoiaʻiʻo i kahi hopena hana kūpono.

Hoʻololi ʻelua: change the requested target amount without changing its definition

E hoʻohālikelike i kahi lako mua liʻiliʻi me kahi lako nui o ke ʻano molekala like a me ka kikoʻī o ka maikaʻi. Pono e hōʻike ʻia ka nui ma muli o ka pono o ka hoʻokolohua. Inā makemake ka haʻawina i ka nui o ka pahuhopu, ʻAʻole ʻokoʻa like ka ʻōlelo nominal synthesis scale a i ʻole ka pauda i hoʻokaʻawale ʻia.

Hiki i ka hoʻonui ʻana i ka nui i noi ʻia ke hoʻololi i ka hui, ka hoomaemae ana, hōʻailona, a me ka hana hoike. ʻAʻole ia e manaʻo i ka piʻi ʻana o ka huahana i ʻae ʻia a i ʻole ke kumukūʻai wānana a me ka manawa hoʻouna. E noi i kahi loiloi kikoʻī i hoʻopaʻa ʻia ma mua o ka hoʻohana ʻana i ka helu kumu kūʻai maʻamau no kēlā me kēia koena.

Selank ʻO ka Peptide Synthesis — E kūkulu i ka noi a puni kahi kuhiakau hoʻāʻo

E hoʻohana i ke kumu i hoʻohālikelike ʻia no nā ʻano ʻelua. ʻO Melanson a me nā haʻawina haʻawina Mai hoʻolohe hōʻike i hoʻokahi ala e pili ana i ka nui maʻiʻo i wehewehe ʻia. ʻAʻole hāʻawi kāna mau ʻano i ka hoʻoponopono āpau no kēlā me kēia lālā o kēia pālua hypothetical.

E koho i ka moho a me nā koi hoʻohālikelike mai ka hoʻolālā i ʻāpono ʻia, me nā ana e pono ai e hoʻokaʻawale i nā wehewehe i koho ʻia. E ʻike ʻia nā haʻawina hoʻomākaukau ʻole. ʻAʻole uku ʻia kahi kauoha ʻoi aku no kahi assay ʻaʻole hiki ke hoʻokaʻawale i ka hiki ke pane mai ka nīnau pili i manaʻo ʻia.

Hiki ke hoʻohana ʻia kahi lako i hoʻonohonoho ʻia inā pane ka pae mua i kahi nīnau kūpono. Pono e maopopo kona mau palena: ʻAʻole hōʻike ka ʻāpana kūleʻa liʻiliʻi i ka loaʻa ʻana o kahi ʻāpana nui aʻe i ka ʻike haumia like, huina kuhi, a i ʻole ka lawelawe ʻana. Pono kēlā me kēia pae i nā hōʻike ʻae kūpono.

Hoʻololi ʻekolu: change analytical scope rather than relying on a higher percentage

E hoʻohālikelike i ka pūʻolo hōʻike no ka pahuhopu like a me ka nui i noi ʻia. Hiki ke pane i kekahi mau nīnau ma kahi ʻano maʻamau a me ka pūʻolo chromatographic; ʻO ka manaʻo hoʻololi-wahi a i ʻole ka hoʻohālikelike quantitative e koi i nā hōʻike hou aku. Pono ka noi analytical e hōʻike i ka nīnau, ʻaʻole wale e noi no ka "hoʻāʻo hou aku." Nūhou

E nīnau pehea e kākoʻo ai ka pūʻolo analytical i ka hoʻohālikelike ma mua o ka noi ʻana i nā hoʻokolohua hou ma ka inoa. ʻike molekala, helu helu a me ka hoʻopili a i ʻole nā ​​moʻolelo hoʻomākaukau i kēlā me kēia ʻōlelo i kahi mea hoʻohālikelike ʻokoʻa. ʻAʻole hiki i ke ʻano kemika ke hoʻokumu i kahi mīkini paʻa, akā, hiki i ka molekala i wehewehe ʻole ʻia a i ʻole ke kumu nui ke pale aku i ka loiloi ʻia ʻana o ia mīkini.

E wehewehe mua i ka hopena e hoʻonāwaliwali ai ke kuhiakau mua. ʻo kahi laʻana, inā nalowale kekahi ʻokoʻa pane ma hope o ka hoʻoponopono ʻana i ka hōʻike, ua hōʻike ʻia paha ka ʻike mua. Inā hoʻomau, pono nā mea ʻē aʻe i nā hōʻike kūpono. Mālama kēia i ka pōkole synthesis e pili ana i kahi hoʻohālikelike hoʻopunipuni ma mua o ka manaʻo e hoʻomaikaʻi ka peptide i hoʻololi ʻia i ka hana.. Nā peptides make-up

Hoʻokaʻawale ka ʻike synthesis maʻamau a Bachem i nā makana maʻamau a me nā makana analytical hou. He laʻana kēia no ke kumu e pono ai ka hōʻoia o ka lawelawe. ʻAʻole ia e hoʻokumu i kēlā me kēia ala i loko o kēlā me kēia ʻōlelo a i ʻole nā ​​​​koho i helu ʻia e hōʻoiaʻiʻo i ka hoʻonā ʻana o ka nīnau hoʻolālā o kēia papahana..

Hoʻopili ʻo Hoofnagle a me nā hoa hana i ka ʻano, ka helu ana, a me ka lawelawe ʻana i nā hoʻokolohua peptide. No ka papahana aʻo, Pono ka pūʻolo hōʻike e kōkua i ke keʻena hana e hoʻomaopopo i ka mea a me ka nui i komo i ka assay, ʻoiai ʻo ka ʻike ʻana ʻaʻole i hoʻokumu ʻia ka hoʻopaʻa ʻana kemika wale nō.

Ua hoʻololi wale ʻia ka hoʻololi Ka hopena qualitative i manaʻo ʻia Uncertain or unsupported inference Useful inquiry
N-terminal free amine versus acetyl group Changes the defined molecular form and local chemistry Direction or magnitude of binding, hikiwawe, or recovery change How will the intended site and matched comparator be specified and assessed?
Requested assigned target amount Changes the amount of acceptable material that must be delivered Linear cost, hua mai, or lead-time scaling What process and purification work supports this requested amount?
Analytical scope Can increase the set of questions the evidence addresses That more tests automatically improve the material or prove function Which uncertainty does each method resolve, and what remains?

This table is qualitative. It contains no invented success rate, optimal purity threshold, or cost estimate. Pono e hōʻoia ʻia nā ʻōlelo kūʻai maoli a me ke ʻano hana no ka ʻōlelo kikoʻī i ʻae ʻia.

Send a reusable brief and resolve the technical questions

kahua pōkole Komo no ka loiloi
Kuhiakau a me ka heluhelu [Hoʻāʻo ʻia ka hopena; kumu hoʻohālike; nā mana kūʻokoʻa a me nā palena wehewehe]
Nā ʻano molekala pololei [Kaʻina, hope, hoʻonohonoho, wahi hoʻololi, a me kekahi lepili]
Ka nui i noi ʻia [Hāʻawi ʻia ka nui a me ke kumu no kēlā me kēia ʻano; hōʻike manaʻo]
ʻO nā hiʻohiʻona kūpono kūpono [ʻIkepili, hōʻike chromatographic, haʻawina maʻiʻo, a me nā nīnau pili hale]
Papa hoʻomākaukau [Mokuaina i hoolakoia, mea i manaoia, kumu noonoo, nā ipu, a me nā nīnau pili ʻole i hoʻoholo ʻia]
Nā mea hoʻouna a me ka manawa [Nā hōʻike pili i ka nui, ʻikepili pili pili, nā pae loiloi, a me nā lā hoʻoholo i koi ʻia]
Hoʻokoe a me ka mālama ʻana i ka ʻike [Nā pae hoʻohālikelike hiki ke hoʻopau, hana hou a i ʻole nā ​​huaʻōlelo pani, pili, a ua ʻae i ka laulā huna]

ʻO kahi noi pōkole: “E ʻoluʻolu e nānā i ka paʻa i hoʻopili ʻia no kā mākou hoʻohālikelike paʻa i ʻōlelo ʻia. E hōʻoia i nā ʻano molekala pololei, kumu nui, nā pilikia kūpono, hōʻike hōʻikeʻike, a me ka hoikeike. E hoʻokaʻawale i ka hana mai ka hana koho, and identify any requirement that cannot currently be supported.”

The technical discussion should answer five questions: What assumptions remain in the structure? How will the assigned amount be supported? Which evidence addresses modification location and relevant impurities? What defines completion and acceptance? What happens if the agreed material cannot be delivered?

Agree on timing in terms of the full delivery, including purification and reporting, rather than treating assembly time as the entire project. Specify how changes will be approved and how confidential sequence or project information may be used. Do not claim that a standard inquiry automatically creates a particular confidentiality obligation.

Approve the molecular pair, quantity basis and assay contrast together. E noi i kēlā me kēia lawelawe synthesis e ʻike i nā mea hiki ke kākoʻo i kāna mau hōʻike a me nā nīnau o lalo e waiho nei me ka hale hana. E mālama i ka hoʻohālikelike i ʻae ʻia i ka wā e loiloi ai i kahi ʻano hoʻopau ʻokoʻa, kahua hoʻopili a hōʻike paha.

Nīnau pinepine

ʻO kahi peptide unacetylated kahi mana maikaʻi ʻole? ʻAʻole. He mea hoʻohālikelike kūkulu ʻia i kēia papahana. ʻO ka hana ʻana ma ke ʻano he mana maikaʻi ʻole e pili ana i ka mīkini a me nā ʻano i ʻike ʻia, ʻaʻole kona lepili.

Hiki i ka mea hoʻolako ke koho i ka pono maʻemaʻe no ka hale hana? Hiki i ka mea hoʻolako ke aʻo e pili ana i ka hiki a me ka laulā analytical. Pono ke keʻena hoʻokolohua e hoʻopili i nā ʻano ʻae i ka hoʻokolohua a ʻae pololei iā lākou.

ʻO ke kauoha nui aʻe e hōʻoiaʻiʻo i ke kumu kūʻai haʻahaʻa no ka nui hoʻohana? ʻAʻole. Hoomaemae, hōʻailona, hoʻihoʻi hou, a e loli paha ka hōʻike. E kiʻi i kahi ʻōlelo no ka hāʻawi like i wehewehe ʻia ma mua o ka manaʻo ʻana i kahi lula hoʻonui honua.

He aha ka mea e hana ai ke hōʻike ka pane ʻenehana i kahi āpau? E hoʻomaopopo i ka hopena hoʻokolohua e pili ana i ke āpau, hoʻoponopono hou i ka ʻōlelo kikoʻī a i ʻole ka papahana hōʻike, a palapala i ka laulā i ʻae ʻia ma mua o ka hana ʻana.

Xiaoxia Chen

Xiaoxia Chen

Laau Laau Hou R&D ʻenehana Kaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.

Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā ​​peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana